We are live on ! Find out more
PCM

Palouse Capital Management Portfolio holdings

AUM $160M
1-Year Est. Return 36.15%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+36.15%
3 Year Est. Return
+67.75%
5 Year Est. Return
+68.17%
10 Year Est. Return
+160.38%
AUM
$234M
AUM Growth
+$9.13M
Cap. Flow
-$7.38M
Cap. Flow %
-3.15%
Top 10 Hldgs %
27.47%
Holding
106
New
11
Increased
20
Reduced
70
Closed
1

Sector Composition

Rank Sector Weight
1 Healthcare 23.66%
2 Technology 15.68%
3 Financials 12.18%
4 Consumer Discretionary 8.77%
5 Energy 6.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
1
AbbVie
ABBV
$433B
$8.27M 3.53%
61,063
-4,436
-7% -$524K
MSFT icon
2
Microsoft
MSFT
$3.62T
$6.64M 2.84%
19,758
-1,076
-5% -$349K
TSN icon
3
Tyson Foods
TSN
$21B
$6.53M 2.79%
74,924
-7,348
-9% -$604K
DVN icon
4
Devon Energy
DVN
$51.4B
$6.48M 2.77%
147,152
-64,861
-31% -$2.7M
NEM icon
5
Newmont
NEM
$100B
$6.44M 2.75%
103,883
-5,645
-5% -$320K
EOG icon
6
EOG Resources
EOG
$77.6B
$6.25M 2.67%
70,366
-2,082
-3% -$187K
VCSH icon
7
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.6B
$6.23M 2.66%
76,634
-13,479
-15% -$1.1M
HBAN icon
8
Huntington Bancshares
HBAN
$35.1B
$6.04M 2.58%
391,417
-17,919
-4% -$282K
PFE icon
9
Pfizer
PFE
$143B
$5.77M 2.47%
97,747
-2,664
-3% -$132K
BMY icon
10
Bristol-Myers Squibb
BMY
$134B
$5.65M 2.41%
90,553
-5,432
-6% -$319K
LMT icon
11
Lockheed Martin
LMT
$135B
$5.61M 2.4%
15,788
-671
-4% -$232K
TAP icon
12
Molson Coors Class B
TAP
$7.86B
$5.17M 2.21%
111,553
-11,102
-9% -$509K
AVGOP
13
DELISTED
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
$5.16M 2.2%
+2,486
New +$4.35M
INTC icon
14
Intel
INTC
$459B
$4.9M 2.09%
95,072
-4,270
-4% -$218K
C icon
15
Citigroup
C
$224B
$4.76M 2.03%
78,826
-7,285
-8% -$484K
JNJ icon
16
Johnson & Johnson
JNJ
$613B
$4.34M 1.85%
25,360
-1,181
-4% -$193K
NTAP icon
17
NetApp
NTAP
$35.9B
$4.22M 1.81%
45,933
-22,785
-33% -$2.05M
PFF icon
18
iShares Preferred and Income Securities ETF
PFF
$13.3B
$4.11M 1.76%
104,276
-6,063
-5% -$236K
IVZ icon
19
Invesco
IVZ
$13.6B
$4.08M 1.75%
177,460
-8,310
-4% -$202K
CVS icon
20
CVS Health
CVS
$134B
$4.02M 1.72%
38,977
-1,320
-3% -$122K
IP icon
21
International Paper
IP
$21.9B
$3.82M 1.63%
81,382
+12,407
+18% +$612K
GILD icon
22
Gilead Sciences
GILD
$163B
$3.65M 1.56%
50,233
-1,078
-2% -$74.2K
AAPL icon
23
Apple
AAPL
$4.46T
$3.64M 1.56%
20,503
-1,292
-6% -$204K
UNH icon
24
UnitedHealth
UNH
$377B
$3.6M 1.54%
7,174
-1,143
-14% -$517K
AMGN icon
25
Amgen
AMGN
$204B
$3.59M 1.53%
15,948
-231
-1% -$48.8K

Similar funds

Palouse Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Palouse Capital Management held 106 positions worth $234M, up 4.1% from $225M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Palouse Capital Management withdrew a net $7.38M in Q4 2021, closing 1 position and reducing 70 holdings. Its most notable exit was Service Corp International, an estimated $275K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 23% a quarter earlier, followed by Technology and Financials.

Against the trend, Palouse Capital Management opened a new position in Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A worth $5.16M.

  • Palouse Capital Management's largest Q4 2021 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 2,486 shares worth $5.16M.
  • Palouse Capital Management added most to International Paper in Q4 2021, an estimated $612K increase.
  • Palouse Capital Management's biggest Q4 2021 reduction was Costco, cutting an estimated $2.94M.
  • Palouse Capital Management fully exited Service Corp International in Q4 2021, selling an estimated $275K.
  • Palouse Capital Management's ten largest holdings make up 27% of its $234M portfolio in Q4 2021.
  • Palouse Capital Management opened 11 new positions and closed 1 in Q4 2021.
  • Palouse Capital Management's portfolio value rose 4.1% quarter-over-quarter to $234M.

Based on Palouse Capital Management's 13F filing for Q4 2021, filed 25 Jan 2022.